# Study to Evaluate the Safety, Tolerability and Pharmacokinetic of Single and 14 Day Repeat Topical Application of GSK1940029

> **NCT01938482** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 55 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** 0.3% GSK1940029 gel
- **DRUG:** 1% GSK1940029 gel
- **DRUG:** 0.3%/1% vehicle gel only

## Key facts

- **NCT ID:** NCT01938482
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10-31
- **Primary completion:** 2015-02-17
- **Final completion:** 2015-02-17
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2017-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01938482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01938482, "Study to Evaluate the Safety, Tolerability and Pharmacokinetic of Single and 14 Day Repeat Topical Application of GSK1940029". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01938482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*